These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 3520601)

  • 1. Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.
    Kjaeldgaard A
    Pharmatherapeutica; 1986; 4(8):525-31. PubMed ID: 3520601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-blind comparison of oral and intravaginal treatments in acute and recurrent vaginal candidosis in general practice.
    Miller PI; Humphries M; Grassick K
    Pharmatherapeutica; 1984; 3(9):582-7. PubMed ID: 6328542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-day treatment of vulvovaginal candidiasis with a 500-mg clotrimazole vaginal tablet compared with a three-day regimen of two 100-mg vaginal tablets daily.
    Floyd R; Hodgson C
    Clin Ther; 1986; 8(2):181-6. PubMed ID: 3698065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-day treatment with butoconazole vaginal suppositories for vulvovaginal candidiasis.
    Adamson GD; Brown D; Standard JV; Henzl MR
    J Reprod Med; 1986 Feb; 31(2):131-2. PubMed ID: 3514908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Terconazole in vaginal candidiasis. A comparative study].
    Llaca Rodríguez V; Carrión Tizcareño H; Arguelles Domenzain P
    Ginecol Obstet Mex; 1990 Nov; 58():328-31. PubMed ID: 2099320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of effectiveness and tolerability of terconazole 80-mg vaginal suppositories (3 days) versus terconazole 240-mg vaginal suppositories (1 day) versus clotrimazole 200-mg vaginal tablets (3 days) in non-pregnant women with vulvovaginal candidosis.
    Loendersloot EW
    Gynakol Rundsch; 1985; 25 Suppl 1():99-104. PubMed ID: 4007627
    [No Abstract]   [Full Text] [Related]  

  • 7. One-day treatment of vaginal candidosis: comparison of terconazole 240-mg suppository with clotrimazole 500-mg vaginal tablet.
    Grice G; Spencer RC; Steele CE; Kinghorn GR
    Gynakol Rundsch; 1985; 25 Suppl 1():83-9. PubMed ID: 3891541
    [No Abstract]   [Full Text] [Related]  

  • 8. [Terconazol in vaginal candidiasis. Comparative study].
    Llaca Rodríguez V; Carrión Tizcareño H; Arguelles Domenzain P
    Ginecol Obstet Mex; 1990 Nov; 58():328-31. PubMed ID: 2083851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 0.8% and 1.6% terconazole cream in severe vulvovaginal candidiasis.
    Schmitt C; Sobel J; Meriwether C
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):414-6. PubMed ID: 2381618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terconazole--a new antifungal agent for vulvovaginal candidiasis.
    Weisberg M
    Clin Ther; 1989; 11(5):659-68. PubMed ID: 2680088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind investigation of R-42470 (terconazole cream 0.4%) and clotrimazole (cream 1%) for the topical treatment of mycotic vaginitis.
    Del Palacio-Hernanz A; Sanz-Sanz F; Rodriquez-Noriega A
    Chemioterapia; 1984 Jun; 3(3):192-5. PubMed ID: 6529776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terconazole for the treatment of vulvovaginal candidiasis.
    Thomason JL; Gelbart SM; Kellett AV; Scaglione NJ; Gotwalt KT; Broekhuizen FF
    J Reprod Med; 1990 Nov; 35(11):992-4. PubMed ID: 2277372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of a three-day and seven-day clotrimazole regimen for vulvovaginal candidiasis.
    Lebherz TB; Ford LC; Kleinkopf V
    Clin Ther; 1981; 3(5):344-8. PubMed ID: 7471129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative double-blind evaluation of the efficacy and tolerability of terconazole 240-mg suppository (1 day) and 80-mg suppositories (3 days) versus clotrimazole 200-mg (3 days) in pregnant patients with vulvovaginal candidosis.
    Goormans E
    Gynakol Rundsch; 1985; 25 Suppl 1():74-82. PubMed ID: 3891540
    [No Abstract]   [Full Text] [Related]  

  • 15. Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis.
    Droegemueller W; Adamson DG; Brown D; Cibley L; Fleury F; LePage ME; Henzl MR
    Obstet Gynecol; 1984 Oct; 64(4):530-4. PubMed ID: 6384848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of vulvovaginal candidiasis with a 500-mg vaginal tablet of clotrimazole.
    Hughes D; Kriedman T
    Clin Ther; 1984; 6(5):662-8. PubMed ID: 6383612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis.
    Friese K; Neumann G; Siebert J
    Arch Gynecol Obstet; 2003 Aug; 268(3):194-7. PubMed ID: 12942250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose 500-mg clotrimazole vaginal tablets compared with placebo in the treatment of Candida vaginitis.
    Bro F
    J Fam Pract; 1990 Aug; 31(2):148-52. PubMed ID: 2199599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose oral fluconazole vs intravaginal terconazole in treatment of Candida vaginitis. Comparison and pilot study.
    Slavin MB; Benrubi GI; Parker R; Griffin CR; Magee MJ
    J Fla Med Assoc; 1992 Oct; 79(10):693-6. PubMed ID: 1460451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses.
    Mendling W; Krauss C; Fladung B
    Mycoses; 2004 Apr; 47(3-4):136-42. PubMed ID: 15078430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.